ProfileGDS4132 / 204629_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 82% 85% 87% 90% 86% 86% 83% 77% 89% 82% 87% 90% 88% 89% 82% 86% 86% 86% 89% 88% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101287.85482
GSM201543Muscle PCOS pioglitazone 121302.92785
GSM201544Muscle PCOS pioglitazone 161387.45187
GSM201545Muscle PCOS pioglitazone 201458.98490
GSM201829Muscle PCOS pioglitazone 231358.46786
GSM201830Muscle PCOS pioglitazon 251344.65786
GSM201831Muscle PCOS pioglitazone 271306.9383
GSM201832Muscle PCOS pioglitazone 31240.4277
GSM201833Muscle PCOS pioglitazone 41395.28289
GSM201834Muscle PCOS pioglitazone 81306.32882
GSM201835Muscle PCOS after pioglitazone 102384.99787
GSM201836Muscle PCOS after pioglitazone 122438.32690
GSM201837Muscle PCOS after pioglitazone 162380.78488
GSM201838Muscle PCOS after pioglitazone 202448.83489
GSM201839Muscle PCOS after pioglitazone 232310.30182
GSM201840Muscle PCOS after pioglitazone 252377.73186
GSM201841Muscle PCOS after pioglitazone 272348.10586
GSM201842Muscle PCOS after pioglitazone 32336.25586
GSM201843Muscle PCOS after pioglitazone 42417.32189
GSM201844Muscle PCOS after pioglitazone 82419.52388